A phase II study of preoperative S-1 plus Paclitaxel combination therapy and postoperative Paclitaxel followed by S-1 therapy for type 4 gastric cancer (OGSG 0502)
Phase 2
- Conditions
- For patients with type 4 gastric cancer
- Registration Number
- JPRN-UMIN000000686
- Lead Sponsor
- OGSG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
Not provided
Exclusion Criteria
1.patients with severe diseases (non-treated ischemic cardiac disease, arrhythmia, liver cirrhosis, nterstitial pneumonia, fresh bleeding which needs transfusion, mental disorder, uncontrolled DM, intestinal obstruction, etc.) 2.febrile infection 3.allergy against polyoxyethylene-castor oil 4.under pregnancy or nursing 5.receiving steroids 6.receiving flucytosine, phenytoin or warfarin 7.doctors' decision
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method "The ratio of the patients who completed the regimen The ratio of administered dose to the planed dose."
- Secondary Outcome Measures
Name Time Method Response Rate Overall Survival Disease Free Survival Histological CR